Illumina company profile

ILMN · NASDAQ · USD

Compare Illumina
$202.61Change from previous close: +2.33%Absolute change: +$4.61

Close · November 17, 2026

Company profile

Illumina has 8,600 employees and is headquartered in San Diego, United States.

The Americas generate the largest share of revenue, 55.4% of the total in the fiscal year ended December 2025, followed by Europe at 29.1%, Asia Pacific, the Middle East and Africa at 9.9%, and China at 5.6%. The company develops sequencing and array platforms for genomic analysis, with instruments and consumables such as reagents, flow cells and library preparation kits. Its whole-genome and targeted resequencing kits cover entire genomes, exomes, specific genes and RNA regions. Customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical and biotechnology companies, commercial molecular diagnostic laboratories and consumer genomics firms. Products are sold directly and through life-science distributors, and services include whole-genome sequencing, genotyping, noninvasive prenatal testing and product support. Collaborations with Labcorp on oncology and with Integrated DNA Technologies on somatic oncology research extend its work.

In the fiscal year ended December 2025, revenue reached USD 4.3 billion, down 0.7% from the prior year, and net income was USD 850 million. The company employed 8,600 people, and it was incorporated in 1998 and headquartered in San Diego, California.

Company facts

Industry
Diagnostics & Research
Headquarters
5200 Illumina Way, 92122, San Diego
Employees
8,600
Chief executive
Jacob Thaysen
Founded
1998
Fiscal year
January - December
Listing
ILMN · NASDAQ
Indices
S&P 500
Currency
USD
ISIN
US4523271090

Illumina and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
IlluminaILMNUnited States$29.94B8,60019.1%34.5
Labcorp HoldingsLHUnited States$30.24B71,00011.2%30.5
Quest DiagnosticsDGXUnited States$28.85B60,00014.9%26.1
Mettler-Toledo InternationalMTDUnited States$34.07B16,60027.8%37.2
NateraNTRAUnited States$41.83B6,135-8.5%—
IQVIA HoldingsIQVUnited States$42.63B95,00013.9%31.5

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Illumina with its competitors